{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:49:02Z","timestamp":1777391342669,"version":"3.51.4"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T00:00:00Z","timestamp":1625443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SCHM 2146\/7-1"],"award-info":[{"award-number":["SCHM 2146\/7-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00ef\u00bf\u00bdr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Zinc-alpha 2-glycoprotein (AZGP1), a secreted protein with ubiquitous tissue expression, has been controversially linked to the risk of cardiovascular disease. In a cohort of kidney transplant recipients, we measured serum AZGP1 levels after transplantation over a 2 year period and tested for an association with pulse wave velocity as an important parameter indicating future cardiovascular events.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Annual blood sampling and pulse wave velocity measurements were longitudinally performed in 113 kidney transplant recipients. AZGP1 was measured in serum samples using standard ELISA. Association of AZGP1 with pulse wave velocity was longitudinally assessed during follow up of 2 years by mixed longitudinal modeling.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> AZGP1 serum levels declined significantly after kidney transplantation. This decline was dependent on allograft function as indicated by inverse correlation with eGFR. When corrected for eGFR multivariable analysis revealed an inverse correlation between AZGP1 and pulse wave velocity. This analysis further showed independent associations of older age, higher blood pressure, and higher calcium phosphate product with higher pulse wave velocity.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> Improved kidney function after transplantation leads to a decline in AZGP1 serum levels. Independent of kidney function and other cardiovascular risk factors lower AZGP1 levels are associated with higher pulse wave velocity in the 2 years after kidney transplantation. These data suggest that AZGP1 might be a potential biomarker for cardiovascular health and a target for improving cardiovascular outcome.<\/jats:p>","DOI":"10.3389\/fcvm.2021.692213","type":"journal-article","created":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T04:53:37Z","timestamp":1625460817000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Changes in AZGP1 Serum Levels and Correlation With Pulse Wave Velocity After Kidney Transplantation"],"prefix":"10.3389","volume":"8","author":[{"given":"Thomas Daniel","family":"Kraemer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inga","family":"Soerensen-Zender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nima","family":"Memaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermann","family":"Haller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anette","family":"Melk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard Magnus Wilhelm","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","article-title":"Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention","volume":"382","author":"Gansevoort","year":"2013","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1681\/ASN.V1191735","article-title":"Explained and unexplained ischemic heart disease risk after renal transplantation","volume":"11","author":"Kasiske","year":"2000","journal-title":"J Am Soc Nephrol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"iii3","DOI":"10.1093\/ndt\/gfl298","article-title":"Cardiovascular risk factors in renal transplantation\u2013current controversies","volume":"21","author":"Marcen","year":"2006","journal-title":"Nephrol Dial Transplant."},{"key":"B5","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1158\/1541-7786.MCR-07-2195","article-title":"Zinc alpha 2-glycoprotein: a multidisciplinary protein","volume":"6","author":"Hassan","year":"2008","journal-title":"Mol Cancer Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.kint.2018.08.010","article-title":"ZAG-a novel biomarker for cardiovascular risk in ESRD patients?","volume":"94","author":"Schmitt","year":"2018","journal-title":"Kidney Int."},{"key":"B7","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s12264-018-00332-x","article-title":"Expression and function of zinc-alpha2-Glycoprotein","volume":"35","author":"Wei","year":"2019","journal-title":"Neurosci Bull."},{"key":"B8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/MCO.0b013e32835f816c","article-title":"Zinc-alpha2-glycoprotein as a marker of fat catabolism in humans","volume":"16","author":"Cabassi","year":"2013","journal-title":"Curr Opin Clin Nutr Metab Care."},{"key":"B9","first-page":"248","article-title":"Zinc-alpha2-Glycoprotein (ZAG): a new deficiency in vitiligo patients","volume":"17","author":"El-Rifaie","year":"2019","journal-title":"Skinmed."},{"key":"B10","doi-asserted-by":"publisher","first-page":"374090","DOI":"10.1155\/2014\/374090","article-title":"Serum levels of the adipokine zinc- alpha 2-glycoprotein are decreased in patients with hypertension","volume":"2014","author":"Zhu","year":"2014","journal-title":"ISRN Endocrinol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.metabol.2010.06.019","article-title":"Serum levels of the adipokine zinc-alpha2-glycoprotein are increased in chronic hemodialysis","volume":"60","author":"Philipp","year":"2011","journal-title":"Metabolism."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e103475","DOI":"10.1371\/journal.pone.0103475","article-title":"The relationship between renal function and plasma concentration of the cachectic factor zinc-alpha2-glycoprotein (ZAG) in adult patients with chronic kidney disease","volume":"9","author":"Pelletier","year":"2014","journal-title":"PLoS ONE."},{"key":"B13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/1471-2369-14-145","article-title":"Zinc-alpha2-glycoprotein in patients with acute and chronic kidney disease","volume":"14","author":"Sorensen-Zender","year":"2013","journal-title":"BMC Nephrol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3389\/fendo.2019.00197","article-title":"Serum zinc-alpha2-glycoprotein levels were decreased in patients with premature coronary artery disease","volume":"10","author":"Liu","year":"2019","journal-title":"Front Endocrinol (Lausanne)."},{"key":"B15","doi-asserted-by":"publisher","first-page":"E1055","DOI":"10.1152\/ajpendo.00075.2019","article-title":"Role of adipokine zinc-alpha2-glycoprotein in coronary heart disease","volume":"317","author":"Huang","year":"2019","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"B16","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.kint.2018.07.019","article-title":"Serum levels of the adipokine zinc-alpha2-glycoprotein (ZAG) predict mortality in hemodialysis patients","volume":"94","author":"Bouchara","year":"2018","journal-title":"Kidney Int."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2020.8594.","article-title":"Sex differences in subclinical cardiovascular organ damage after renal transplantation: a single-center cohort study","author":"Stocklassa","year":"2020","journal-title":"J Womens Health."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation."},{"key":"B19","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S0895-7061(01)02326-3","article-title":"Clinical applications of arterial stiffness, Task Force III: recommendations for user procedures","volume":"15","author":"Van Bortel","year":"2002","journal-title":"Am J Hypertens."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/ajh.2011.147","article-title":"Validating a new oscillometric device for aortic pulse wave velocity measurements in children and adolescents","volume":"24","author":"Kracht","year":"2011","journal-title":"Am J Hypertens."},{"key":"B22","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/ndt\/gfz053","article-title":"Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategies","volume":"34","author":"Rangaswami","year":"2019","journal-title":"Nephrol Dial Transplant."},{"key":"B23","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1172\/JCI108371","article-title":"Renal handling of Zn-alpha2-glycoprotein as compared with that of albumin and the retinol-binding protein","volume":"57","author":"Ekman","year":"1976","journal-title":"J Clin Invest."},{"key":"B24","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/ki.2013.9","article-title":"White adipose tissue overproduces the lipid-mobilizing factor zinc alpha2-glycoprotein in chronic kidney disease","volume":"83","author":"Pelletier","year":"2013","journal-title":"Kidney Int."},{"key":"B25","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/j.1365-2796.2011.02441.x","article-title":"Adipose zinc-alpha2-glycoprotein is a catabolic marker in cancer and noncancerous states","volume":"271","author":"Ryden","year":"2012","journal-title":"J Intern Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.3109\/0886022X.2012.712859","article-title":"Zinc-alpha2-glycoprotein: is there association between this new adipokine and body composition in hemodialysis patients?","volume":"34","author":"Leal","year":"2012","journal-title":"Ren Fail."},{"key":"B27","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s40620-018-0549-4","article-title":"Cardiovascular risk in renal transplant recipients","volume":"32","author":"Devine","year":"2019","journal-title":"J Nephrol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"32887","DOI":"10.1038\/srep32887","article-title":"Sodium-Glucose Cotransporter 2 (SGLT2) inhibitor increases circulating zinc-alpha2-glycoprotein levels in patients with type 2 diabetes","volume":"6","author":"Liao","year":"2016","journal-title":"Sci Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12882-015-0092-7","article-title":"Assessment of arterial stiffness using pulse wave velocity in tacrolimus users the first year post kidney transplantation: a prospective cohort study","volume":"16","author":"Birdwell","year":"2015","journal-title":"BMC Nephrol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.transproceed.2014.12.014","article-title":"Prediction of cardiovascular events after renal transplantation","volume":"47","author":"Seibert","year":"2015","journal-title":"Transplant Proc."},{"key":"B31","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s11255-020-02376-3","article-title":"Kidney transplantation improves arterial stiffness in patients with end-stage renal disease","volume":"52","author":"Feng","year":"2020","journal-title":"Int Urol Nephrol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.12659\/AOT.881992","article-title":"Progressive arterial stiffening in kidney transplant recipients","volume":"16","author":"Strozecki","year":"2011","journal-title":"Ann Transplant."},{"key":"B33","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12872-019-01309-y","article-title":"Progression of endothelial dysfunction, atherosclerosis, and arterial stiffness in stable kidney transplant patients: a pilot study","volume":"20","author":"Junarta","year":"2020","journal-title":"BMC Cardiovasc Disord."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1097\/HJH.0000000000002058","article-title":"Impact of kidney transplantation on aortic stiffness and aortic stiffness index beta0","volume":"37","author":"Desjardins","year":"2019","journal-title":"J Hypertens."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.692213\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T04:53:42Z","timestamp":1625460822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.692213\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,5]]},"references-count":34,"alternative-id":["10.3389\/fcvm.2021.692213"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.692213","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,5]]},"article-number":"692213"}}